Sublingual allergen immunotherapy with a liquid birch pollen product in seasonal allergic rhinoconjunctivitis with/without asthma*

The current pivotal phase III study confirmed clinical efficacy as well as safety of a high-dose liquid SLIT product. (Source: Journal of Allergy and Clinical Immunology)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Q6dc9x